Risks of Adverse Events in Treated Chronic Hepatitis C Patients with Cirrhosis Compared to without Cirrhosis in Real-World Settings

被引:0
|
作者
Shen, Sophie W. [1 ]
Ives, Jennifer Wood [1 ]
Hines, Patricia [2 ]
Dimitrova, Dessislava [1 ]
机构
[1] Bristol Myers Squibb Co, Global Pharmacovigilance & Epidemiol, Hopewell, NJ USA
[2] Bristol Myers Squibb Co, Ctr Observat Res & Data Sci, Hopewell, NJ USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
128
引用
收藏
页码:65 / 66
页数:2
相关论文
共 50 条
  • [41] Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan
    Toyoda, Hidenori
    Atsukawa, Masanori
    Watanabe, Tsunamasa
    Nakamuta, Makoto
    Uojima, Haruki
    Nozaki, Akito
    Takaguchi, Koichi
    Fujioka, Shinichi
    Iio, Etsuko
    Shima, Toshihide
    Akahane, Takehiro
    Fukunishi, Shinya
    Asano, Toru
    Michitaka, Kojiro
    Tsuji, Kunihiko
    Abe, Hiroshi
    Mikami, Shigeru
    Okubo, Hironao
    Okubo, Tomomi
    Shimada, Noritomo
    Ishikawa, Toru
    Moriya, Akio
    Tani, Joji
    Morishita, Asahiro
    Ogawa, Chikara
    Tachi, Yoshihiko
    Ikeda, Hiroki
    Yamashita, Naoki
    Yasuda, Satoshi
    Chuma, Makoto
    Tsutsui, Akemi
    Hiraoka, Atsushi
    Ikegami, Tadashi
    Genda, Takuya
    Tsubota, Akihito
    Masaki, Tsutomu
    Iwakiri, Katsuhiko
    Kumada, Takashi
    Tanaka, Yasuhito
    Okanoue, Takeshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (08) : 1420 - 1425
  • [42] Poor Adherence to Screening for Hepatocellular Carcinoma (HCC), Especially in Patients with Chronic Hepatitis B (CHB) Without Cirrhosis Compared to Patients with Cirrhosis of All Etiologies
    Wong, Carrie R.
    Garcia, Ruel T.
    Trinh, Huy N.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Levitt, Brian S.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2009, 136 (05) : A835 - A836
  • [43] Real World Utilization and Management of Adverse Events in Patients Treated with Direct Acting Antivirals (DAAs) in a European Cohort of Chronic Hepatitis C (CHC) Patients
    Ahmed, Shirin
    Chretin, Stephanie
    Mast, T. Christopher
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 298 - 299
  • [44] Hepatitis C Prevalence in Patients With Hepatocellular Carcinoma Without Cirrhosis
    Madhoun, Mohammad F.
    Fazili, Javid
    Bright, Brianna C.
    Bader, Ted
    Roberts, David N.
    Bronze, Michael S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (02): : 169 - 173
  • [45] Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis
    Koshy, A
    Marcellin, P
    Martinot, M
    Madda, JP
    LIVER, 2000, 20 (04): : 335 - 339
  • [46] Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
    Alessio Aghemo
    Yves Horsmans
    Stefan Bourgeois
    Mark Bondin
    Michael Gschwantler
    Harald Hofer
    Nasser Semmo
    Francesco Negro
    Zhenzhen Zhang
    John Marcinak
    Ella Veitsman
    Rawi Hazzan
    Konstantinos Mimidis
    Ioannis Goulis
    Nuno Marques
    Robert Flisiak
    Wlodzimierz Mazur
    Carlos Roncero
    Fiona Marra
    Georges Philippe Pageaux
    Tarik Asselah
    Pietro Lampertico
    Infectious Diseases and Therapy, 2021, 10 : 2203 - 2222
  • [47] Real-World Treatment Patterns and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in the UK: A Preliminary Analysis
    Xie, Jing
    Yong, Alan
    Waweru, Catherine
    Sorof, Thuy Anh
    Goyal, Ravi K.
    Davis, Keith L.
    Follows, George
    Hillmen, Peter
    BLOOD, 2019, 134
  • [48] Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UK
    Hillmen, Peter
    Xie, Jing
    Yong, Alan S. M.
    Waweru, Catherine
    Sorof, Thuy Anh
    Goyal, Ravi K.
    Davis, Keith L.
    EJHAEM, 2021, 2 (02): : 219 - 227
  • [49] Adverse Events in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography with and without Liver Cirrhosis
    Jagtap, Nitin
    Lakhtakia, Sundeep
    Tandan, Manu
    Ramchandani, Mohan
    Kalapala, Rakesh
    Gupta, Rajesh
    Reddy, N. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 224 - 224
  • [50] Efficacy and Safety of Sofosbuvir and Velpatasvir Combination for the Treatment of Chronic Hepatitis C in Patients With or Without Cirrhosis
    Shah, Islam
    Ahmad, Wiqas
    Qadir, Abdul
    Muhammad, Iltaf
    Islam, Muhammad
    Shah, Mustaqeem
    Jan, Naeem
    Anjum, Sadia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)